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Cesarean scar pregnancy is a rare type of ectopic pregnancy associated with severe complications such as uterine rupture, un-
controllable bleeding which may lead to hysterectomy, and deﬁnitive infertility. Many therapeutic options are available such
as Dilatation & Curetage, excision of trophoblastic tissues using either laparotomy or laparoscopy, systemically administered
Methotrexate, and more recently uterine artery embolization. The use of Methotrexate sometimes required laparotomy later
because of severe hemorrhage. Through this paper, we demonstrated that viable cesarean scar pregnancy can be managed safely by
systemically delivered Methotrexate at the cost of a prolonged followup.
1.Introduction
Cesarean scar pregnancy (CSP) is an ectopic pregnancy
implanted in the myometrium at the site of a previous
cesarean section scar. It is the rarest kind of ectopic preg-
nancy and may lead to severe complications, such as uterine
disruption and severe hemorrhage [1]. Thus, it is important
thatearlyandaccuratediagnosisisobtainedinordertoavoid
complications and preserve fertility. Several types of con-
servative treatment have been used: dilatation and curettage,
excision of trophoblastic tissues (laparotomy or laparoscopy)
[2, 3], local and/or systemic administration of methotrexate
[4], bilateral hypogastric artery ligation associated with tro-
phoblastic evacuation, and selective uterine artery emboliza-
tion combined with curettage and/or MTX administration
[5, 6].
In this paper, we describe a case of viable cesarean
scar pregnancy that was treated successfully by systemically
administered MTX followed by a dilatation and curettage
under ultrasound guidance.
2. The Case
A 35-year-old female, gravida 2 para 1, with a previous
history of cesarean section, was admitted to hospital for
vaginal bleeding at 6-week gestation. Physical examination
demonstrated stable vital signs while bimanual examina-
tion revealed an enlarged uterus with no adnexal masses.
Transvaginal ultrasound revealed a 36mm well-deﬁned
gestational sac with a crown-rump length of 11,6mm and
a fetal cardiac activity in the lower anterior wall of the
uterus (Figures 1 and 2). Only 1,3mm of myometrium
was visualized in the anterior wall of the cervix (Figure 3).
There was no ﬂuid in the cul-de-sac. The serum level of
the ß-subunit of human chorionic gonadotrophin (ß-hCG)
was 8332mUI/mL. These ﬁndings were compatible with
a cesarean scar pregnancy. A magnetic resonance imaging
revealed that the gestational sac was implanted at the site of
thepreviouscesareansectionscar,comingdowntotheserosa
without the interposition of the myometrium (Figures 4
and 5), conﬁrming the diagnosis. The patient was counseled2 Case Reports in Obstetrics and Gynecology
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Figure 1: Transvaginal ultrasound image of the scar pregnancy crown-rump length 11.6mm with fetal cardiac activity.
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Figure 2: Transvaginal ultrasound image of the scar pregnancy. Gestational sac in the lower anterior wall of the uterus (arrow head), empty
uterus (arrow).Case Reports in Obstetrics and Gynecology 3
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Figure 3: Transvaginal ultrasound image of the scar pregnancy only 1.3mm of myometrium visualized in the anterior wall of the cervix,
empty cervical canal (arrow).
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Figure 4: Magnetic resonance imaging cesarean scar pregnancy, empty uterus (arrow), empty cervical canal (arrow head).4 Case Reports in Obstetrics and Gynecology
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Figure 5: Magnetic resonance imaging gestational sac surrounded by myometrium (arrow head), absence of myometrium between the
gestational sac and the bladder (arrow).
regardinghermanagementoptions,andsinceshehadaprior
cesarean in the past, had opted for medical treatment. Thus,
she received a ﬁrst dose (Day 0) of Methotrexate (75mg:
1mg/Kg of body weight) intramuscularly. The serum level
of the ß-subunit of human Chorionic Gonadotrophin at
the 4th day was 18157mUI/mL requiring a second dose
of methotrexate. This second dose was followed by a mild
vaginal bleeding. The ß-hCG levels at day 8 decreased to
12562mUI/mL, and the patient was discharged and followed
up by outpatient until a total negativation of ß-hCG levels, at
day 34. The transvaginal ultrasound revealed the persistence
of a gestational sac without fetus, so we decided to proceed
to a D and C under ultrasound guidance. Ten days after
the D and C, it was conﬁrmed that the patient had no
vaginal bleeding, no pain, and undetectable level of serum ß-
hCG. An oral contraception has been prescribed. A control
hysterosalpingography was realized, 2 months after the
curettage in order to evaluate the scar. It did not reveal any
continuity solution nor any ﬁstula.
3. Discussion
The increasing rate of cesarean sections in the two last
decades has brought into light a set of complications that
were not so frequent in the past, including Cesarean scar
pregnancy. This condition is deﬁned as a gestation com-
pletely surrounded by myometrium and ﬁbrous tissues of
the cesarean section scar and separated from endometrium
cavity and endocervical canal [7] .T h eﬁ r s tc a s ew a sr e p o r t e d
in 1978 (Larsen and Solomon) as a postabortal haemorrhage
due to what the authors called a uterine scar sacculus [8].
Since then, cases have been reported leading to a better
understanding.
The possible incidence of this type of ectopic pregnancy
ranges from 1/1800 to 1/2200 pregnancies [9]. The case
reported occurred within a period of 12 months during
which a total of 62 ectopic pregnancies were diagnosed in
our departement.
The pathophysiology of cesarean scar pregnancy remains
to be established, but it is possible that the conceptus
penetratesthemyometriumthroughamicroscopicdehiscent
tract of the cesarean scar [3] or the gestational sac implanta-
tion occurs in a poor healed cesarean section scar. It may also
result from a defect in the endometrium caused by trauma
created by procedures in assisted reproduction techniques
[10].
The natural history of this condition remains unclear, it
mayresultinapregnancythatloosesitsvascularconnections
while growing, thus causing a spontaneous abortion, or
it may continue to grow gaining new stronger vascular
connections ending into a low-lying adherent placenta with
or without invasion of surrounding organs [11]. Early
diagnosis is thus important to avoid serious complications.
The most common symptom is painless vaginal bleeding
that may be massive. Since there is no speciﬁc clinical sign
of the CSP, endovaginal ultrasonography and color ﬂow
Doppler are essential for diagnosis. The sonographic criteria
for diagnosis [12, 13]a r eCase Reports in Obstetrics and Gynecology 5
(i) empty uterus and empty cervical canal;
(ii) development of the sac in the anterior wall of the
isthmic portion;
(iii) a discontinuity on the anterior wall of the uterus
demonstrated on a sagittal plane of the uterus
running through the amniotic sac;
(iv) absent or diminished healthy myometrium between
the bladder and the sac;
(v) high velocity with low impedance peri-trophoblastic
vascular ﬂow clearly surrounding the sac is proposed
in Doppler examination.
Miscarriages (Abortion and missed abortion) and cervi-
coisthmical pregnancies can be sources of confusion in the
diagnosis of CSP. Ultrasonography is a precious diagnostic
instrument to diﬀerentiate these conditions. The diﬀeren-
tiating points between CSP and cervicoisthmical pregnancy
include the absence of healthy uterine tissues between the sac
and the bladder [12].
Because of the rarity of the CSP, there are no optimal
lines for therapy. Treatment modalities are either medical or
surgicalandaresometimescombined.Thesurgicalapproach
includes radical and conservative procedures. The radical
procedure consists in hysterectomy when the uterus is rup-
tured or if bleeding is uncontrollable. The conservative pro-
cedure includes (i) evacuation of the pregnancy and repair of
the uterine defect by laparotomy or laparoscopy [12, 14], (ii)
dilatation and curettage and excision of trophoblastic tissues
using laparotomy or laparoscopy [2, 3, 15], and (iii) bilateral
hypogastric artery ligation associated with D and C under
laparoscopic guidance [16]. The medical treatment consists
of MTX administration locally or systemically [13, 17]s o m e
authors combine MTX injected into the sac and potassium
chlorideinjectedlocallyintothefetalheart[18].Themedical
treatmentrequiresaprolongedfollowup(thehCGleveltakes
up to 4 months to return to normal) [19] and implies a high
cost. Bleeding may occur following the MTX injection as in
the reported case, which may require surgical intervention.
Failureofpregnancyresorptionandpersistanceofarelatively
large gestational sac may imply a dilatation and curettage or
a laparoscopic intervention. Another important issue is the
condition of the uterine scar left after medical treatment and
its subsequent behavior in future pregnancies (dehiscences
are reported) [20].
Another treatment possibility is the uterine artery em-
bolisation UAE [5, 7, 14] ,w h i c hi sw i d e l ya c c e p t e da s
a conservative treatment in postpartum hemorrhage, in
uterine ﬁbroids, it is also considered as the best method
to prevent massive bleeding during D and C for cervical
pregnancy. Although UAE seems to be promising in treating
stable cases, it’s not recommended as a primary line therapy.
In our case, since the patient was stable and did not want
to have a surgical procedure and since there was no facilities
forUAE,weoptedformedicaltreatment.TheuseofDandC
was dictated by the persistence of the gestational sac, despite
the negativity of hCG.
TheimmediatecomplicationsofCSPareuterinerupture,
severe hemorrhage, need for hysterectomy, and maternal
morbidity. Long-term outcomes to be considered after
medical, UAE, or conservative surgical treatments are future
fertility and recurrence of CSP. A study of 2007 [18]r e p o rt e d
a favorable reproductive outcomes and a low recurrence rate.
4. Conclusion
In this observation, we demonstrated that viable CSP can
be treated safely by systemic methotrexate injection and
subsequent dilatation and curettage. Decisions on treatment
options should be dictated in part by gestational age, hCG
levels, the presence of fetal cardiac activity, the desire of
future fertility, and the experience and facilities available.
Counselling patients with CSP is not easy, since there is no
data about the optimum treatment. More reports are needed
to rationalize the treatment modalities on this condition.
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